FR2805824B1 - Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 - Google Patents

Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21

Info

Publication number
FR2805824B1
FR2805824B1 FR0002795A FR0002795A FR2805824B1 FR 2805824 B1 FR2805824 B1 FR 2805824B1 FR 0002795 A FR0002795 A FR 0002795A FR 0002795 A FR0002795 A FR 0002795A FR 2805824 B1 FR2805824 B1 FR 2805824B1
Authority
FR
France
Prior art keywords
trisomy
cytotrophoblasts
crops
markers
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0002795A
Other languages
English (en)
Other versions
FR2805824A1 (fr
Inventor
Brion Danielle Evain
Jean Louis Frendo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR0002795A priority Critical patent/FR2805824B1/fr
Priority to PCT/FR2001/000619 priority patent/WO2001065264A1/fr
Priority to CA002401603A priority patent/CA2401603A1/fr
Priority to EP01913925A priority patent/EP1259824A1/fr
Priority to US10/220,433 priority patent/US20030138435A1/en
Priority to JP2001563908A priority patent/JP2003525056A/ja
Publication of FR2805824A1 publication Critical patent/FR2805824A1/fr
Application granted granted Critical
Publication of FR2805824B1 publication Critical patent/FR2805824B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/38—Pediatrics
    • G01N2800/385—Congenital anomalies
    • G01N2800/387—Down syndrome; Trisomy 18; Trisomy 13

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pregnancy & Childbirth (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR0002795A 2000-03-03 2000-03-03 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21 Expired - Fee Related FR2805824B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0002795A FR2805824B1 (fr) 2000-03-03 2000-03-03 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21
PCT/FR2001/000619 WO2001065264A1 (fr) 2000-03-03 2001-03-02 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21
CA002401603A CA2401603A1 (fr) 2000-03-03 2001-03-02 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21
EP01913925A EP1259824A1 (fr) 2000-03-03 2001-03-02 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21
US10/220,433 US20030138435A1 (en) 2000-03-03 2001-03-02 Trisomy 21 cytotrophoblast cultures,and uses thereof for obtaining trisomy 21 markers
JP2001563908A JP2003525056A (ja) 2000-03-03 2001-03-02 トリソミー２１の細胞栄養芽層培養物、及びトリソミー２１マーカーを得るためのその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0002795A FR2805824B1 (fr) 2000-03-03 2000-03-03 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21

Publications (2)

Publication Number Publication Date
FR2805824A1 FR2805824A1 (fr) 2001-09-07
FR2805824B1 true FR2805824B1 (fr) 2002-05-03

Family

ID=8847721

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0002795A Expired - Fee Related FR2805824B1 (fr) 2000-03-03 2000-03-03 Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21

Country Status (6)

Country Link
US (1) US20030138435A1 (fr)
EP (1) EP1259824A1 (fr)
JP (1) JP2003525056A (fr)
CA (1) CA2401603A1 (fr)
FR (1) FR2805824B1 (fr)
WO (1) WO2001065264A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5629051B2 (ja) * 2005-03-18 2014-11-19 ザ チャイニーズ ユニバーシティー オブ ホンコンＴｈｅ Ｃｈｉｎｅｓｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｈｏｎｇｋｏｎｇ 出生前診断およびモニタリングのためのマーカー
CN114167057B (zh) * 2021-12-10 2024-04-19 大连医科大学 一种诊断流产的生物学标志物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2894889A (en) * 1988-02-01 1989-08-03 Monoclonetics International Incorporated Genetic markers for down's syndrome, fetal abnormalities and twins

Also Published As

Publication number Publication date
FR2805824A1 (fr) 2001-09-07
WO2001065264A1 (fr) 2001-09-07
JP2003525056A (ja) 2003-08-26
US20030138435A1 (en) 2003-07-24
EP1259824A1 (fr) 2002-11-27
CA2401603A1 (fr) 2001-09-07

Similar Documents

Publication Publication Date Title
FR2804683B1 (fr) Monoacylarylphosphines organometalliques, leur preparation et leur utilisation pour la preparation d'acylphosphines asymetriques utiles comme photoamorceurs
MA27126A1 (fr) 3'PROMEDICAMENTS DE 2'-DESOXY- β-L-NUCLEOSIDES
DZ3347A1 (fr) Dérivés d'arylméthylamine pour leur utilisation comme inhibiteurs de la tryptase
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
FR2814380B1 (fr) Poudre de microcapsules et procede d'obtention
SG100740A1 (en) Disposable pants of trunks-type
FR2864312B1 (fr) Carte de manoeuvrabilite laterale pour mobile et son procede d'obtention
FR2805456B1 (fr) Prothese totale de genou, du type dit "postero-stabilisee"
FR2762217B1 (fr) Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
FR2805824B1 (fr) Cultures de cytotrophoblastes de trisomie 21, et leur utilisation pour l'obtention de marqueurs de la trisomie 21
FR2797442B1 (fr) Derives acetamido de calixarenes, leur preparation et leur utilisation pour l'extraction du strontium
FR2822846B1 (fr) Procede de preparation et de selection d'anticorps
ITFI20000145A0 (it) Carrello "intelligente" per servizi commerciali
FR2829927B1 (fr) Nouvelles compositions cosmetiques et leur procede d'obtention
FR2792532B1 (fr) Nouvelles compositions antiseptiques et leur procede d'obtention
HUP0303286A3 (en) Compositions and methods for the discovery and selection of biological information
FR2823751B1 (fr) Nouveaux composes de la famille des 3-alkyl-(4,5 diphenyl- imidazol-1-yl) et leur utilisation comme anti-inflammatoires
FR2832149B1 (fr) Nouveaux inhibiteurs de l'angiogenese et leur utilisation pharmaceutique et cosmetique
AU2001251462A1 (en) Compositions and methods for detection of von willebrand's disease
FR2804112B1 (fr) Procede d'obtention de cyclotrimeres d'isocyanate(s) ramifie(s) faiblement colore(s) et composition en decoulant
ITMI20000810A0 (it) Procedimento per la preparazione di 5'-acetilstavudina
IL155526A0 (en) Compositions and methods for the discovery and selection of biological information
FR2808528B1 (fr) Procede d'obtention de polyisocyanate(s) ramifie(s) faiblement colore(s), et composition en decoulant
FR2812720B1 (fr) Baton de defense et d'attaque, en particulier pour les forces de l'ordre
FR2792315B1 (fr) Nouvelles benzodioxinones et leur procede d'obtention

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091130